Onc Now: Breaking Barriers in Cancer Immunotherapy

Onc Now

In this episode, Bjørn Henning Grønberg explores the evolving landscape of lung cancer care, progress and remaining challenges in small-cell lung cancer, clinical research collaboration, emerging treatment approaches, quality of life, and care for older patients.

Speaker bio:

Andrew Furness

Andrew Furness is a consultant medical oncologist at the Royal Marsden Hospital, London, UK, treating patients with skin and kidney cancers. He is also Team Leader and Clinical Lead of the Centre for Translational Immunotherapy at the Institute of Cancer Research, London, UK.

Timestamps:

00:00 – Introduction
01:10 – Journey into medical oncology
07:11 – Translational immunotherapy research
11:50 – Tumour-infiltrating lymphocyte therapy
21:30 – Cellular therapy infrastructure barriers
26:35 – Improving immunotherapy patient selection
31:21 – ESMO and emerging areas
32:45 – Three wishes for immunotherapy

Disclaimer: The opinions expressed in this episode belong to the speakers and do not necessarily represent the opinions of EMJ.

Onc Now: Breaking Barriers in Cancer Immunotherapy

Onc Now

Personalised Cancer Vaccine Shows Promise in Head and Neck Cancer

Rabies Virus Glycoprotein Directs CAR-T Cells to Attack Glioma

More articles

Interview: Félix Guerrero-Ramos

The Future of Gynaecologic Cancer Care with Bhavana Pothuri

Journey Through the Evolving Lung Cancer Space

Featured journals

AMJ Oncology 3.1 2026

AMJ Oncology 3 [Supplement 4] 2026

Therapy Area

About Us

Onc Now: Breaking Barriers in Cancer Immunotherapy

Onc Now

Related To This Subject

Personalised Cancer Vaccine Shows Promise in Head and Neck Cancer

Rabies Virus Glycoprotein Directs CAR-T Cells to Attack Glioma

More articles

Interview: Félix Guerrero-Ramos

The Future of Gynaecologic Cancer Care with Bhavana Pothuri

Journey Through the Evolving Lung Cancer Space

Featured journals

AMJ Oncology 3.1 2026

AMJ Oncology 3 [Supplement 4] 2026